Procyon Advisors
BMY icon

Procyon Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Procyon Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$910K Sell
14,584
-2,134
-13% -$135K 0.04% 291
2026
Q2 		$963K Sell
16,718
-1,469
-8% -$84.4K 0.04% 277
2026
Q1 		$1.1M Buy
18,187
+2,735
+18% +$159K 0.05% 259
2025
Q4 		$833K Sell
15,452
-20,349
-57% -$979K 0.04% 285
2025
Q3 		$1.61M Buy
35,801
+8,907
+33% +$416K 0.1% 171
2025
Q2 		$1.24M Sell
26,894
-1,529
-5% -$75.1K 0.12% 163
2025
Q1 		$1.73M Buy
28,423
+9,763
+52% +$569K 0.1% 193
2024
Q4 		$1.06M Buy
18,660
+1,423
+8% +$79.5K 0.07% 232
2024
Q3 		$891K Buy
17,237
+572
+3% +$26.8K 0.06% 252
2024
Q2 		$692K Buy
16,665
+1,858
+13% +$83.1K 0.05% 269
2024
Q1 		$803K Buy
14,807
+5,595
+61% +$285K 0.06% 253
2023
Q4 		$473K Sell
9,212
-4,350
-32% -$228K 0.04% 323
2023
Q3 		$787K Buy
13,562
+2,135
+19% +$131K 0.08% 224
2023
Q2 		$731K Buy
11,427
+1,487
+15% +$100K 0.09% 207
2023
Q1 		$689K Sell
9,940
-645
-6% -$45.5K 0.11% 172
2022
Q4 		$762K Buy
10,585
+1,365
+15% +$103K 0.14% 152
2022
Q3 		$655K Sell
9,220
-2,756
-23% -$200K 0.16% 127
2022
Q2 		$922K Sell
11,976
-3,646
-23% -$278K 0.2% 106
2022
Q1 		$1.14M Buy
15,622
+4,946
+46% +$332K 0.24% 92
2021
Q4 		$666K Buy
10,676
+5,548
+108% +$325K 0.14% 141
2021
Q3 		$303K Buy
5,128
+61
+1% +$4.02K 0.08% 233
2021
Q2 		$339K Sell
5,067
-676
-12% -$44.1K 0.09% 190
2021
Q1 		$363K Sell
5,743
-298
-5% -$18.5K 0.16% 147
2020
Q4 		$375K Sell
6,041
-118
-2% -$7.26K 0.18% 136
2020
Q3 		$371K Buy
6,159
+21
+0.3% +$1.26K 0.21% 116
2020
Q2 		$361K Buy
6,138
+357
+6% +$21.4K 0.19% 110
2020
Q1 		$322K Sell
5,781
-43
-0.7% -$2.63K 0.21% 99
2019
Q4 		$374K Buy
+5,824
New +$334K 0.23% 96

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Procyon Advisors's BMY Position: Q3 2026 in Review

Procyon Advisors reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2026, selling an estimated $135K and leaving 14,584 shares worth $910K. The position accounts for 0.04% of the portfolio, ranked #291.

Procyon Advisors first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.73M in Q1 2025. 1,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Procyon Advisors held 14,584 shares of Bristol-Myers Squibb worth $910K as of Q3 2026.
  • Procyon Advisors sold 2,134 Bristol-Myers Squibb shares in Q3 2026, an estimated $135K.
  • Bristol-Myers Squibb made up 0.04% of Procyon Advisors's portfolio in Q3 2026, its #291 holding.
  • Procyon Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • Procyon Advisors's Bristol-Myers Squibb position peaked at $1.73M in Q1 2025.
  • 1,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.